These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21906168)
1. A proposed approach to the dialysis prescription in severely hyponatremic patients with end-stage renal disease. Wendland EM; Kaplan AA Semin Dial; 2012; 25(1):82-5. PubMed ID: 21906168 [TBL] [Abstract][Full Text] [Related]
2. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Hecking M; Karaboyas A; Saran R; Sen A; Hörl WH; Pisoni RL; Robinson BM; Sunder-Plassmann G; Port FK Am J Kidney Dis; 2012 Feb; 59(2):238-48. PubMed ID: 21944663 [TBL] [Abstract][Full Text] [Related]
3. Successful management of severe hyponatremia in CKD-VD: In a cost limited setting. Pattanashetti N; Bharati J; Kohli HS; Gupta KL; Ramachandran R Hemodial Int; 2019 Apr; 23(2):E69-E71. PubMed ID: 30773820 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe hyponatremia in a patient with renal failure using continuous venovenous hemodialysis. Bender FH Am J Kidney Dis; 1998 Nov; 32(5):829-31. PubMed ID: 9820455 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Zeltser D; Rosansky S; van Rensburg H; Verbalis JG; Smith N; Am J Nephrol; 2007; 27(5):447-57. PubMed ID: 17664863 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of extreme hyponatremia in an anuric patient using continuous venovenous hemodialysis. Viktorsdottir O; Indridason OS; Palsson R Blood Purif; 2013; 36(3-4):274-9. PubMed ID: 24496199 [TBL] [Abstract][Full Text] [Related]
7. A standard hemodialysis prescription to prevent osmotic demyelination in hyponatremic patients requiring dialysis. Koc NS; Yildirim T; Girgin S; Onal C; Tahillioglu Y; Yilmaz R; Arici M; Altun B; Erdem Y Ther Apher Dial; 2022 Dec; 26(6):1182-1186. PubMed ID: 35199958 [TBL] [Abstract][Full Text] [Related]
8. Effects of lowering dialysate sodium on flow-mediated dilatation in patients with chronic kidney disease. Aybal Kutlugün A; Erdem Y; Okutucu S; Yorgun H; Atalar E; Arici M Nephrol Dial Transplant; 2011 Nov; 26(11):3678-82. PubMed ID: 21421595 [TBL] [Abstract][Full Text] [Related]
9. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances. Song JH; Park GH; Lee SY; Lee SW; Lee SW; Kim MJ J Am Soc Nephrol; 2005 Jan; 16(1):237-46. PubMed ID: 15563561 [TBL] [Abstract][Full Text] [Related]
10. Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid. Yessayan L; Yee J; Frinak S; Szamosfalvi B Am J Kidney Dis; 2014 Aug; 64(2):305-10. PubMed ID: 24792353 [TBL] [Abstract][Full Text] [Related]
11. Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain. Tarhan NC; Agildere AM; Benli US; Ozdemir FN; Aytekin C; Can U AJR Am J Roentgenol; 2004 Mar; 182(3):809-16. PubMed ID: 14975990 [TBL] [Abstract][Full Text] [Related]
12. Hyponatremia and hypokalemia in patients on peritoneal dialysis. Zanger R Semin Dial; 2010; 23(6):575-80. PubMed ID: 21121953 [TBL] [Abstract][Full Text] [Related]
13. Central pontine and extrapontine myelinolysis after rapid correction of hyponatremia by hemodialysis in a uremic patient. Huang WY; Weng WC; Peng TI; Ro LS; Yang CW; Chen KH Ren Fail; 2007; 29(5):635-8. PubMed ID: 17654329 [TBL] [Abstract][Full Text] [Related]
14. The role of sequential ultrafiltration and varying dialysate sodium on vascular stability during hemodialysis. Po CL; Afolabi M; Raja RM ASAIO J; 1993; 39(3):M798-800. PubMed ID: 8268648 [TBL] [Abstract][Full Text] [Related]
15. Relation between serum sodium levels and prognosis in outpatients with chronic heart failure: neutral effect of treatment with beta-blockers and angiotensin-converting enzyme inhibitors: data from the Italian Network on Congestive Heart Failure (IN-CHF database). Baldasseroni S; Urso R; Orso F; Bianchini BP; Carbonieri E; Cirò A; Gonzini L; Leonardi G; Marchionni N; Maggioni AP; J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):723-31. PubMed ID: 21873881 [TBL] [Abstract][Full Text] [Related]
16. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Elsharkawy MM; Youssef AM; Zayoon MY Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745 [TBL] [Abstract][Full Text] [Related]
17. Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system. Manlucu J; Gallo K; Heidenheim PA; Lindsay RM Am J Kidney Dis; 2010 Jul; 56(1):69-76. PubMed ID: 20303632 [TBL] [Abstract][Full Text] [Related]
18. Individualized reduction in dialysate sodium in conventional in-center hemodialysis. Arramreddy R; Sun SJ; Munoz Mendoza J; Chertow GM; Schiller B Hemodial Int; 2012 Oct; 16(4):473-80. PubMed ID: 22554224 [TBL] [Abstract][Full Text] [Related]
19. Dialysate Sodium: Choosing the Optimal Hemodialysis Bath. Munoz Mendoza J; Arramreddy R; Schiller B Am J Kidney Dis; 2015 Oct; 66(4):710-20. PubMed ID: 25987259 [TBL] [Abstract][Full Text] [Related]
20. Dialysate sodium, serum sodium and mortality in maintenance hemodialysis. Mc Causland FR; Brunelli SM; Waikar SS Nephrol Dial Transplant; 2012 Apr; 27(4):1613-8. PubMed ID: 21891777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]